Ptc Therapeutics annual shares outstanding
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ptc Therapeutics Shares Outstanding History (PTCT)
Ptc Therapeutics reported 81.5M shares outstanding at the end of fiscal 2025.
View full Ptc Therapeutics company overviewPtc Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 81.5M | 3.8M | +4.85% |
| 2024 | 2024-12-31 | 77.7M | 2.0M | +2.64% |
| 2023 | 2023-12-31 | 75.7M | 2.6M | +3.56% |
| 2022 | 2022-12-31 | 73.1M | 2.3M | +3.21% |
| 2021 | 2021-12-31 | 70.8M | 1.1M | +1.59% |
| 2020 | 2020-12-31 | 69.7M | 7.8M | +12.56% |
| 2019 | 2019-12-31 | 61.9M | 11.3M | +22.39% |
| 2018 | 2018-12-31 | 50.6M | 9.0M | +21.61% |
| 2017 | 2017-12-31 | 41.6M | 7.4M | +21.78% |
| 2016 | 2016-12-31 | 34.2M | 252,851 | +0.75% |
| 2015 | 2015-12-31 | 33.9M | 1.0M | +3.09% |
| 2014 | 2014-12-31 | 32.9M | 9.1M | +38.21% |
| 2013 | 2013-12-31 | 23.8M | 23.8M | +525823.16% |
| 2012 | 2012-12-31 | 4,526 | — | — |
Ptc Therapeutics quarterly shares outstanding
Q4.12
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 83.3M | 3.9M | +4.98% |
| Q1 2026 | 2026-03-31 | 82.9M | 3.7M | +4.62% |
| Q4 2025 | 2025-12-31 | 81.5M | 3.8M | +4.85% |
| Q3 2025 | 2025-09-30 | 79.9M | 3.0M | +3.87% |
| Q2 2025 | 2025-06-30 | 79.4M | 2.5M | +3.22% |
| Q1 2025 | 2025-03-31 | 79.2M | 2.6M | +3.35% |
| Q4 2024 | 2024-12-31 | 77.7M | 2.0M | +2.64% |
| Q3 2024 | 2024-09-30 | 77.0M | 1.5M | +1.98% |
| Q2 2024 | 2024-06-30 | 76.9M | 1.6M | +2.10% |
| Q1 2024 | 2024-03-31 | 76.7M | 2.6M | +3.57% |
| Q4 2023 | 2023-12-31 | 75.7M | 2.6M | +3.56% |
| Q3 2023 | 2023-09-30 | 75.5M | 3.6M | +5.02% |
| Q2 2023 | 2023-06-30 | 75.3M | 3.8M | +5.33% |
| Q1 2023 | 2023-03-31 | 74.0M | 2.7M | +3.75% |
| Q4 2022 | 2022-12-31 | 73.1M | 2.3M | +3.21% |
| Q3 2022 | 2022-09-30 | 71.9M | 1.2M | +1.68% |
| Q2 2022 | 2022-06-30 | 71.5M | 946,559 | +1.34% |
| Q1 2022 | 2022-03-31 | 71.3M | 931,136 | +1.32% |
| Q4 2021 | 2021-12-31 | 70.8M | 1.1M | +1.59% |
| Q3 2021 | 2021-09-30 | 70.7M | 2.9M | +4.21% |
| Q2 2021 | 2021-06-30 | 70.6M | 2.9M | +4.22% |
| Q1 2021 | 2021-03-31 | 70.4M | 7.6M | +12.19% |
| Q4 2020 | 2020-12-31 | 69.7M | 7.8M | +12.56% |
| Q3 2020 | 2020-09-30 | 67.8M | 6.2M | +10.12% |
| Q2 2020 | 2020-06-30 | 67.7M | 10.0M | +17.32% |
| Q1 2020 | 2020-03-31 | 62.8M | 4.3M | +7.43% |
| Q4 2019 | 2019-12-31 | 61.9M | 11.3M | +22.39% |
| Q3 2019 | 2019-09-30 | 61.6M | 11.1M | +22.10% |
| Q2 2019 | 2019-06-30 | 57.7M | 11.0M | +23.62% |
| Q1 2019 | 2019-03-31 | 58.4M | 16.6M | +39.73% |
| Q4 2018 | 2018-12-31 | 50.6M | 9.0M | +21.61% |
| Q3 2018 | 2018-09-30 | 50.4M | 9.0M | +21.63% |
| Q2 2018 | 2018-06-30 | 46.7M | 5.4M | +13.02% |
| Q1 2018 | 2018-03-31 | 41.8M | 7.5M | +21.83% |
| Q4 2017 | 2017-12-31 | 41.6M | 7.4M | +21.78% |
| Q3 2017 | 2017-09-30 | 41.5M | 7.3M | +21.36% |
| Q2 2017 | 2017-06-30 | 41.3M | 7.2M | +21.19% |
| Q1 2017 | 2017-03-31 | 34.3M | 397,152 | +1.17% |
| Q4 2016 | 2016-12-31 | 34.2M | 252,851 | +0.75% |
| Q3 2016 | 2016-09-30 | 34.2M | 250,460 | +0.74% |
| Q2 2016 | 2016-06-30 | 34.1M | 210,363 | +0.62% |
| Q1 2016 | 2016-03-31 | 33.9M | 436,378 | +1.30% |
| Q4 2015 | 2015-12-31 | 33.9M | 1.0M | +3.09% |
| Q3 2015 | 2015-09-30 | 33.9M | 4.5M | +15.46% |
| Q2 2015 | 2015-06-30 | 33.9M | 4.5M | +15.45% |
| Q1 2015 | 2015-03-31 | 33.5M | 4.2M | +14.18% |
| Q4 2014 | 2014-12-31 | 32.9M | 9.1M | +38.21% |
| Q3 2014 | 2014-09-30 | 29.4M | 5.6M | +23.40% |
| Q2 2014 | 2014-06-30 | 29.3M | 5.5M | +23.26% |
| Q1 2014 | 2014-03-31 | 29.3M | — | — |
| Q4 2013 | 2013-12-31 | 23.8M | 23.8M | +525823.16% |
| Q3 2013 | 2013-09-30 | 23.8M | — | — |
| Q2 2013 | 2013-06-30 | 23.8M | — | — |
| Q4 2012 | 2012-12-31 | 4,526 | — | — |
Ptc Therapeutics shares outstanding trends
Over the last five fiscal years, Ptc Therapeutics's shares outstanding moved from 69.7M to 81.5M, a change of 11.8M. The latest reported quarter, Q2 2026, shows 83.3M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ptc Therapeutics source filings ↗Community posts
PTC raises its revenue forecast as Sephience sales expand
PTC Therapeutics ($PTCT) raised its full-year 2026 revenue expectation to $1.29–$1.32 billion and increased product-sales guidance to $960–$990 million from $850–$950 million. Third-quarter 2026 product and royalty revenue reached $357.6 mi ...
